Dai Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmacology top 5%
- Biological and pharmacological studies of plants
Papers in
-
- Biological Activity of Diterpenoids and Biflavonoids 4
- Natural product bioactivities and synthesis 4
- RNA modifications and cancer 4
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Pulmonary Hypertension Research and Treatments 5
- Ferroptosis and cancer prognosis 5
- Co-authors
- Qi Li (1 shared paper)Fan Wu (1 shared paper)Yuanyuan Jing (1 shared paper)Rong Li (1 shared paper)Haiyu Zhou (1 shared paper)Feng Sui (1 shared paper)Yun‐Peng Sui (1 shared paper)Hai-Ru Huo (1 shared paper)
- Journals
- European Journal of Pharmacology (5 papers)International Immunopharmacology (4 papers)Canadian Journal of Physiology and Pharmacology (4 papers)Medicine (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dai Li
101 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 235
- Pharmacology 271
- Molecular Biology 884
- Immunology 208
- Complementary and alternative medicine 73
Countries citing papers authored by Dai Li
This map shows the geographic impact of Dai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Li more than expected).
Fields of papers citing papers by Dai Li
This network shows the impact of papers produced by Dai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Li. The network helps show where Dai Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Dai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 245 | |
| 2 | 2017 | 191 | |
| 3 | 2008 | 75 | |
| 4 | 2017 | 74 | |
| 5 | 2019 | 56 | |
| 6 | 2018 | 54 | |
| 7 | 2018 | 54 | |
| 8 | 2016 | 53 | |
| 9 | 2018 | 53 | |
| 10 | 2020 | 42 | |
| 11 | 2016 | 41 | |
| 12 | 2011 | 39 | |
| 13 | 2023 | 38 | |
| 14 | 2022 | 36 | |
| 15 | 2016 | 35 | |
| 16 | 2017 | 34 | |
| 17 | 2019 | 34 | |
| 18 | 2019 | 33 | |
| 19 | 2017 | 33 | |
| 20 | 2017 | 30 |
About Dai Li
Dai Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology, Immunology and Oncology, having authored 107 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pulmonary Hypertension Research and Treatments (5 papers), Ferroptosis and cancer prognosis (5 papers), Biological Activity of Diterpenoids and Biflavonoids (4 papers), Natural product bioactivities and synthesis (4 papers), RNA modifications and cancer (4 papers) and Intracerebral and Subarachnoid Hemorrhage Research (3 papers). The work is most often cited by research in Cancer Research (235 citations), Pharmacology (271 citations), Molecular Biology (884 citations), Immunology (208 citations) and Complementary and alternative medicine (73 citations). Dai Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qi Li, Fan Wu, Yuanyuan Jing, Rong Li, Haiyu Zhou, Feng Sui, Yun‐Peng Sui, Hai-Ru Huo, Xin-Liang Du and Jiang Ting-liang. Their work appears in journals such as European Journal of Pharmacology, International Immunopharmacology, Canadian Journal of Physiology and Pharmacology, Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.